GCT
AZN icon

Galaxy Capital Trading’s AstraZeneca AZN Stock Holding History

Galaxy Capital Trading’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-13,300
Closed -$629K – 201
2013
Q2 		$629K Buy
+13,300
New +$677K 0.54% 36

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Galaxy Capital Trading's AZN Position: Q3 2013 in Review

Galaxy Capital Trading sold out of AstraZeneca (AZN) in Q3 2013, closing a stake of 13,300 shares — an estimated $629K sold.

Galaxy Capital Trading first reported a position in AZN in Q2 2013 and held it in 1 quarter. The position peaked at $629K in Q2 2013. 343 funds tracked by Wall St. Rank hold AZN as of Q3 2013.

  • Galaxy Capital Trading reported no remaining AstraZeneca position as of Q3 2013 after selling out during the quarter.
  • Galaxy Capital Trading sold 13,300 AstraZeneca shares in Q3 2013, an estimated $629K.
  • Galaxy Capital Trading first reported a position in AstraZeneca in Q2 2013 and held it in 1 quarter.
  • Galaxy Capital Trading's AstraZeneca position peaked at $629K in Q2 2013.
  • 343 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2013.

Based on Galaxy Capital Trading's 13F filing for Q3 2013, filed 4 Oct 2013.